Stuttgart- Start of a new trial site

On the 21st May 2026, the Klinikum Stuttgart became officially another active trial site of the STOP-PKD Study. The team of Prof. Dr.Vedat Schwenger cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Stuttgart to obtain detailed information about the trial and potential participation.

Phone: +49 711 278-35356

Email: studienzentrum-nephrologie@klinikum-stuttgart.de